Corvus Pharmaceuticals CRVS Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Corvus Pharmaceuticals's net change in cash?
- Corvus Pharmaceuticals (CRVS) reported net change in cash of $35.53M in Q1 2026.
- How has Corvus Pharmaceuticals's net change in cash changed year-over-year?
- Corvus Pharmaceuticals's net change in cash increased by 1049.6% year-over-year, from -$3.74M to $35.53M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.